` ABTI (Alterola Biotech Inc) vs S&P 500 Comparison - Alpha Spread

ABTI
vs
S&P 500

Over the past 12 months, ABTI has significantly outperformed S&P 500, delivering a return of +42% compared to the S&P 500's +15% growth.

Stocks Performance
ABTI vs S&P 500

Loading
ABTI
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ABTI vs S&P 500

Loading
ABTI
S&P 500
Difference
www.alphaspread.com

Performance By Year
ABTI vs S&P 500

Loading
ABTI
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Alterola Biotech Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Alterola Biotech Inc
Glance View

Market Cap
7.4m USD
Industry
Consumer products

Alterola Biotech, Inc. develops medical cannabis products. The company is headquartered in Walnut, California. The company went IPO on 2010-03-09. The firm is focused on developing pharmaceutical medicines made from cannabinoid, cannabinoid-like and non-cannabinoid active pharmaceutical ingredients (APIs) globally. The company is also focused on developing non-pharmaceutical (nutraceutical / dietary supplement) products containing cannabinoids, cannabinoid-like and non-cannabinoid food-grade ingredients. In addition, the Company is focused on supplying cosmetic ingredients to potential customers who develops products containing cannabinoids, cannabinoid-like and non-cannabinoid ingredients.

ABTI Intrinsic Value
Not Available
Back to Top